Mass Torts

September 1, 2026

Hernia Mesh Lawsuit Against C.R. Bard

C.R. Bard is defending over 18,000 hernia mesh lawsuits, which allege that its mesh devices were defective, resulting in injuries and complications for thousands of patients undergoing hernia surgery. Most of these lawsuits have now been joined in the Bard hernia mesh settlement, although new claims continue to come to our office virtually every day.

Our hernia mesh lawyers are handling these claims in all 50 states. We are still taking new claims. This page will provide the latest news and updates on the hernia mesh litigation, as well as information regarding the settlement value of these cases.

Call our lawyers at 800-553-8082 for a free consultation or reach out online.

August 4, 2026

Truvada Lawsuit

by Ronald V. Miller, Jr.

This page is about Truvada lawsuits and other HIV drug injury lawsuits involving kidney or bone injuries.

HIV drugs containing tenofovir disoproxil fumarate (TDF) are, we believe, putting patients at risk. This has resulted in HIV drug lawsuits from victims alleging kidney disease and failure, bone density loss, bone injuries, and other side effects.

Viread® and Truvada® are two of the first brand-name drugs developed by Gilead Sciences to treat HIV. Viread and Truvada both use tenofovir disoproxil fumarate (TDF), a new type of antiviral drug that was one of the first effective treatments for slowing HIV.

July 31, 2026

Taxotere Eye Injury Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are handling Taxotere eye injury lawsuits throughout the United States for women with permanently watery eyes from docetaxel.

Taxotere (docetaxel) is a widely used breast cancer chemotherapy drug. New evidence has emerged showing that Taxotere may be causing some users to suffer permanent vision loss or damage.

This has led to a wave of product liability Taxotere lawsuits by women who claim that Taxotere damaged their eyesight. The manufacturer of Taxotere, Sanofi, allegedly knew about the risk of vision damage but chose not to warn doctors or patients about this risk.

July 23, 2026

Chlorpyrifos Lawsuits

by Ronald V. Miller, Jr.

Chlorpyrifos lawsuits allege that repeated exposure to this widely used insecticide can contribute to Parkinson’s disease. The people most likely to bring these claims are farmers, pesticide applicators, pest control workers, groundskeepers, greenhouse employees, and others who personally mixed, loaded, sprayed, or cleaned up chlorpyrifos products over months or years.

Chlorpyrifos was sold under trade names that include Dursban, Lorsban, Cobalt, Nufos, Bolton, Stallion, Pilot, Warhawk, and Hatchet. It was used on farms, golf courses, ornamental plants, and residential and commercial properties. Many workers remember the trade name but not the active ingredient. Product identification is therefore one of the first and most important parts of investigating a claim.

If you have Parkinson’s disease after years of working with pesticides, you may have wondered whether that exposure played a role. A December 2025 study gives lawyers and scientists a serious reason to investigate chlorpyrifos. Researchers associated estimated long-term residential exposure near agricultural applications with more than 2.5 times the risk of Parkinson’s disease. They also found Parkinson’s-related brain damage in mice that inhaled chlorpyrifos.

July 14, 2026

Tylenol Autism Lawsuit

by Ronald V. Miller, Jr.

Tylenol autism lawsuits are being filed nationwide with a new Tylenol Autism class action lawsuit – technically an MDL, as we explain below – now certified in federal court.

Another Path For Victims – Baby Food

There may be another path to compensation for some victims. Plaintiffs’ Tylenol lawyers are exploring options in state court (and looking at potential baby food lawsuits for children with autism.. Those lawsuits are gaining new currency after the Tylenol cases faltered in the MDL.

July 3, 2026

Glucose Monitor Lawsuits

by Ronald V. Miller, Jr.

Glucose monitor lawsuits are being filed by people who say continuous glucose monitoring systems failed when they needed them most. These lawsuits involve Dexcom G6, Dexcom G7, Abbott FreeStyle Libre 3, and Abbott FreeStyle Libre 3 Plus sensors, apps, and receivers that allegedly provided inaccurate glucose readings, missed high- or low-glucose alerts, failed early, or failed to warn users that glucose data had stopped reporting.

This is no small complaint for someone with diabetes who relies on these monitors. A continuous glucose monitor can drive decisions about insulin, food, sleep, exercise, and emergency care. When a sensor falsely reports low glucose, a patient may eat carbohydrates or delay insulin. When a device misses a low alert, a patient may seize, lose consciousness, fall, or die. When a high glucose event is missed, the result can be prolonged hyperglycemia, diabetic ketoacidosis, hospitalization, or worse. Of course, a malfunctioning glucose monitor typically causes more minor injuries and inconveniences.

Our lawyers are looking for serious glucose monitor cases involving serious injury or death.

June 29, 2026

AFFF Firefighting Foam Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are handling AFFF firefighting foam lawsuits around the country.

This page provides the most recent news and updates on the AFFF firefighting foam class action lawsuit and our prediction of the settlement amounts that plaintiffs with AFFF cancer lawsuits can expect to receive. You will not get more updated news on the AFFF litigation anywhere else.

Our AFFF firefighting foam lawyers believe the defendants will settle most of these lawsuits this year (2026) before a single trial. Why? They will follow the same pattern as the water contamination lawsuits they settled for billions of dollars. In those cases, we saw the defendants’ apparent preference for settlement over the uncertainties of a trial. This makes sense; the AFFF lawsuits are strong cases.

June 28, 2026

3M Earplug Lawsuit Update

by Ronald V. Miller, Jr.

This page provides the latest news and updates on the 3M earplug lawsuits and the settlement in 2024. We continue to update this page to provide information to victims, but you can find even more quality information from other plaintiffs in the over 10,000 comments below. We are not handling new 3M earplug lawsuits. Continue reading

June 18, 2026

Oxbryta Lawsuit Settlement

by Ronald V. Miller, Jr.

For sickle cell patients and families, Oxbryta was supposed to be a lifeline. Instead, it left many worse off–facing new health crises, hospitalizations, and in some cases, unthinkable loss. Now, Oxbryta lawsuits are uncovering what Pfizer knew and when it knew it.

Oxbryta is a prescription drug developed by Global Blood Therapeutics and later acquired by Pfizer. It was voluntarily recalled in September 2024 after new evidence revealed that it caused serious and potentially fatal complications, including vaso-occlusive crises and organ damage.

This page looks at Oxbryta lawsuits and their potential settlement value.

Oxbryta is a prescription drug made by Pfizer that was recalled in September 2024 after evidence revealed that it caused a number of very serious and potentially fatal health problems, including vaso-occlusive crisis and organ damage. Continue reading

June 17, 2026

Internal Bra Mesh Lawsuit

by Ronald V. Miller, Jr.

Breast mesh lawsuits allege that some manufacturers promoted or allowed their mesh products to become widely used in breast reconstruction, augmentation, and revision procedures despite the fact that FDA has not cleared or approved any surgical mesh product for use in breast surgery. The FDA has specifically stated that the safety and effectiveness of surgical mesh in breast surgery, including augmentation and reconstruction, has not been determined.

These internal bra lawsuits allege that manufacturers of products such as AlloDerm, GalaFLEX, Phasix, AlloMax, FlexHD, Strattice, and DuroSorb marketed their devices for breast reconstruction, augmentation, and revision surgeries even though those breast-specific applications had not been adequately studied or cleared by the FDA. Patients were not warned. Surgeons were not given enough information. So when complications developed, including infection, mesh failure, chronic pain, implant loss, breast deformity, and the need for additional surgery, many women had no reason to connect their injuries to the mesh product placed inside them.

This page explains the internal bra mesh lawsuit. Our lawyers talk about what the legal claims are, who may be eligible, what complications may qualify, how to identify your mesh product, what evidence matters, and what these cases may be worth.